Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial
- 29 April 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 28 (8), 931-946
- https://doi.org/10.1007/s10067-009-1180-5
Abstract
Andrographis paniculata (Burm. f.) Wall ex Nees (Acanthaceae) possesses anti-inflammatory effects, attributed to the main constituent andrographolide proposed as alternative in the treatment of autoimmune disease. A prospective, randomized, double blind, and placebo-controlled study in patients with rheumatoid arthritis (RA) was performed. Tablets (Paractin®) made of an extract of A. paniculata (30% total andrographolides) were administered three times a day for 14 weeks, after a 2-week washout period to 60 patients with active RA. The primary outcomes were pain intensity measured using a horizontal visual analog pain scale (VAPS). In addition, ACR, EULAR, and SF36 clinical parameters were recorded. The intensity of joint pain decreased in the active vs placebo group at the end of treatment, although these differences were not statistically significant. A significant diminishing for week in tender joint −0.13 95% confidence interval (CI; −0.22 to 0.06; p = 0.001), number of swollen joints −0.15 95%CI (−0.29 to −0.02; p = 0.02), total grade of swollen joint −0.27 95%CI (−0.48 to −0.07; p = 0.010), number of tender joints −0.25 95%CI (−0.48 to −0.02; p = 0.033), total grade of swollen joints −0.27 95%CI (−0.48 to −0.07; p = 0.01), total grade of tender joints −0.47 95%CI (−0.77 to −0.17; p = 0.002) and HAQ −0.52 95%CI (−0.82 to −0.21; p < 0.001) and SF36 0.02 95%CI (0.01 to 0.02; p < 0.001) health questionnaires was observed within the group with the active drug. Moreover, it was associated to a reduction of rheumatoid factor, IgA, and C4. These findings suggest that A. paniculata could be a useful “natural complement” in the treatment of AR; however, a larger trial and a more extended period of treatment is necessary in order to corroborate these results.Keywords
This publication has 60 references indexed in Scilit:
- MAPKs and their relevance to arthritis and inflammationRheumatology, 2007
- Andrographolide Inhibits the Production of TNF-.ALPHA. and Interleukin-12 in Lipopolysaccharide-Stimulated Macrophages: Role of Mitogen-Activated Protein KinasesBiological & Pharmaceutical Bulletin, 2006
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005
- Double-blind, placebo-controlled pilot and Phase III study of activity of standardized Andrographis paniculata Herba Nees extract fixed combination (Kan jang) in the treatment of uncomplicated upper-respiratory tract infectionPhytomedicine, 2000
- Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and humanPhytomedicine, 2000
- Activation of T cells by superantigen: cytokine production but not apoptosis depends on MEK-1 activityEuropean Journal of Immunology, 1998
- Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteriaArthritis & Rheumatism, 1996
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- IgM-rheumatoid factor and responses to second-line drugs in rheumatoid arthritisInflammation Research, 1991
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988